Hans Strid

4.5k total citations
94 papers, 3.3k citations indexed

About

Hans Strid is a scholar working on Genetics, Epidemiology and Gastroenterology. According to data from OpenAlex, Hans Strid has authored 94 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Genetics, 47 papers in Epidemiology and 36 papers in Gastroenterology. Recurrent topics in Hans Strid's work include Inflammatory Bowel Disease (60 papers), Microscopic Colitis (46 papers) and Gastrointestinal motility and disorders (33 papers). Hans Strid is often cited by papers focused on Inflammatory Bowel Disease (60 papers), Microscopic Colitis (46 papers) and Gastrointestinal motility and disorders (33 papers). Hans Strid collaborates with scholars based in Sweden, United States and United Kingdom. Hans Strid's co-authors include Magnus Simrén, Lena Öhman, Stefan Isaksson, Anders Lasson, Antal Bajor, Maria K. Magnusson, Per‐Ove Stotzer, Riadh Sadik, Iris Posserud and Maria Sapnara and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Hans Strid

85 papers receiving 3.2k citations

Peers

Countries citing papers authored by Hans Strid

Since Specialization

Citations

This map shows the geographic impact of Hans Strid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Strid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Strid more than expected).

Fields of papers citing papers by Hans Strid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Strid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Strid. The network helps show where Hans Strid may publish in the future.

Co-authorship network of co-authors of Hans Strid

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Strid. A scholar is included among the top collaborators of Hans Strid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Strid. Hans Strid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study 2025 ·BJS Open ·Erik Stenberg, Åsa H. Everhov, Jonas Söderling, Johan Ottosson, Mehdi Osooli, (unknown), Pär Myrelid, Hans Strid, Caroline Nordenvall, Charlotte Hedin, Susanna Jäghult, (unknown), O Grip, Ulrika L. Fagerberg, Karl Mårild, Ellen Andersson, Daniel Bergemalm, Jonas F. Ludvigsson, Carl Eriksson, Ola Olén	0
2	Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: a nationwide cohort study 2025 ·Journal of Crohn s and Colitis ·Jordan E. Axelrad, Anders Forss, (unknown), Karl Mårild, Jonas Halfvarson, Pontus Nauclér, Jonas F. Ludvigsson, Ola Olén, (unknown), Pär Myrelid, (unknown), Hans Strid, Marie Andersson, Susanna Jäghult, Caroline Nordenvall, Charlotte Hedin, (unknown), Olof Grip, Ulrika L. Fagerberg, Jóhann P. Hreinsson	0
3	Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD 2024 ·Alimentary Pharmacology & Therapeutics ·(unknown), Christer Peterson, Charlotte Hedin, Daniel Bergemalm, Maria Lampinen, Maria K. Magnusson, Åsa V. Keita, (unknown), C. Lindqvist, Dirk Repsilber, Mauro D’Amato, (unknown), Hans Strid, Johan D. Söderholm, Lena Öhman, Per Venge, Jonas Halfvarson, Marie Carlson	7
4	Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study 2023 ·Therapeutic Advances in Gastroenterology ·(unknown), Carl Eriksson, (unknown), (unknown), Per Karlén, Olof Grip, Charlotte Söderman, Sven Almér, Erik Hertervig, Jan Marsal, (unknown), (unknown), Hans Strid, (unknown), Daniel Bergemalm, Henrik Hjortswang, Jonas Halfvarson	4
5	Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register 2022 ·United European Gastroenterology Journal ·(unknown), (unknown), Charlotte Hedin, Anders Forss, Charlotte Söderman, Daniel Bergemalm, (unknown), Ola Olén, Henrik Hjortswang, Hans Strid, Jonas F. Ludvigsson, Carl Eriksson, Jonas Halfvarson	29
6	Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG 2021 ·Scandinavian Journal of Gastroenterology ·Carl Eriksson, (unknown), Lina Vigren, (unknown), Anders Kärnell, Henrik Hjortswang, Daniel Bergemalm, (unknown), Sven Almér, Erik Hertervig, Per Karlén, Hans Strid, Jonas Halfvarson	6
7	Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study 2021 ·Therapeutic Advances in Gastroenterology ·Carl Eriksson, (unknown), (unknown), Ruzan Udumyan, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almér, Erik Hertervig, Jan Marsal, (unknown), (unknown), (unknown), Hans Strid, (unknown), (unknown), Daniel Bergemalm, Henrik Hjortswang, Jonas Halfvarson, (unknown)	19
8	Clinical effectiveness of golimumab in Crohn’s disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG) 2018 ·Scandinavian Journal of Gastroenterology ·(unknown), Carl Eriksson, (unknown), (unknown), Susanna Jäghult, Jan Björk, Olof Grip, Henrik Hjortswang, Hans Strid, Per Karlén, Scott Montgomery, Jonas Halfvarson	8
9	IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being 2016 ·Inflammatory Bowel Diseases ·(unknown), Lena Öhman, Magnus Simrén, Hans Strid	72
10	European Crohn's and Colitis Organisation Topical Review on environmental factors in IBD 2016 ·Journal of Crohn s and Colitis ·Christian Maaser, Ebbe Langholz, Hannah Gordon, Johan Burisch, Pierre Ellul, Vicent Hernández, Tarkan Karakan, Κωνσταντίνος Κατσάνος, Eduards Krustiņš, Arie Levine, Gerassimos J. Mantzaris, Colm O’Morain, Elif Sarıtaş Yüksel, Hans Strid, Vito Annese	38
11	Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled study 2014 ·United European Gastroenterology Journal ·Anders Lasson, Lena Öhman, Per‐Ove Stotzer, Stefan Isaksson, (unknown), Kjell–Arne Ung, Hans Strid	42
12	Response to Infliximab Therapy in Ulcerative Colitis is Associated With Decreased Monocyte Activation, Reduced CCL2 Expression and Downregulation of Tenascin C 2014 ·Journal of Crohn s and Colitis ·Maria K. Magnusson, Hans Strid, Stefan Isaksson, Antal Bajor, Anders Lasson, Kjell–Arne Ung, Lena Öhman	38
13	Spontaneous Colitis in Muc2-Deficient Mice Reflects Clinical and Cellular Features of Active Ulcerative Colitis 2014 ·PLoS ONE ·Ulf Alexander Wenzel, Maria K. Magnusson, Anna Rydström, (unknown), Julia Hengst, Malin Johansson, Anna Velcich, Lena Öhman, Hans Strid, Henrik Sjövall, Gunnar C. Hansson, Mary Jo Wick	93
14	The unsaponifiable fraction of extra virgin olive oil promotes apoptosis and attenuates activation and homing properties of T cells from patients with inflammatory bowel disease 2014 ·Food Chemistry ·Ana Cárdeno, Maria K. Magnusson, Hans Strid, Catalina Alarcón‐de‐la‐Lastra, Marina Sánchéz‐Hidalgo, Lena Öhman	32
15	CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis 2013 ·United European Gastroenterology Journal ·Maria K. Magnusson, Rahil Dahlén, Hans Strid, Stefan Isaksson, Magnus Simrén, Anders Lasson, Antal Bajor, Kjell–Arne Ung, Lena Öhman	11
16	Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity 2013 ·Journal of Crohn s and Colitis ·Hans Strid, Magnus Simrén, Anders Lasson, Stefan Isaksson, Mats Stridsberg, Lena Öhman	17
17	Overuse of acid suppressive therapy in hospitalised patients with pulmonary diseases 2003 ·Respiratory Medicine ·Anna Niklasson, Antal Bajor, (unknown), Magnus Simrén, Hans Strid, E. Björnsson	31
18	Overuse of acid suppressant drugs in patients with chronic renal failure 2003 ·Nephrology Dialysis Transplantation ·Hans Strid	65
19	The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being 2002 ·Nephrology Dialysis Transplantation ·Hans Strid	103
20	Impact of Sex and Psychological Factors on the Water Loading Test in Functional Dyspepsia 2001 ·Scandinavian Journal of Gastroenterology ·Hans Strid, (unknown), (unknown), Magnus Simrén, Jan Svedlund, Hasse Abrahamsson, Einar S. Björnsson	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact